Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/41526
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Moreno, Beatriz | - |
dc.contributor.author | Villoslada, Pablo | - |
dc.contributor.author | Messeguer, Joaquim | - |
dc.contributor.author | Navarro-Vendrell, Gloria | - |
dc.contributor.author | Messeguer Peypoch, Ángel | - |
dc.date.accessioned | 2011-10-21T08:02:52Z | - |
dc.date.available | 2011-10-21T08:02:52Z | - |
dc.date.issued | 2011-03-03 | - |
dc.identifier.citation | WO2011024078 A1 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10261/41526 | - |
dc.description.abstract | New 3-oxopiperazinium derivatives agonists ofNerve Growth Factor receptors and their use as medicaments. Neurotrophin binding to its specific receptor Trk A leads to the activation of multiple signalling cascades, culminating in neuroregenerative effects, incIuding neuronal survival and neurite outgrowth. Neurotrophic factors have been used for the treatment of several neurodegenerative diseases. However, their use is limited by their inability to cross the blood-brain barrier, their short half life and their side effects. Small molecule neurotrophin peptidomimetics may be beneficial in treating a number of neurodegenerative disorders. The present invention shows the capacity of nerve growth factor agonist molecules derived from the 3- oxopiperazinium scaffold to induce differentiation in PC12 cells and, therefore, that these small molecules with NGF agonist activity may be beneficial for treatment of neurodegenerative diseases, due to their neuroregenerative effects. | es_ES |
dc.language.iso | eng | es_ES |
dc.rights | openAccess | es_ES |
dc.title | 3- Oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments | es_ES |
dc.type | solicitud de patente | es_ES |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.description.assignee | Institut d´investigacions Biomediques August P11 Sunyer (IDIBAPS), Consejo Superior de Investigaciones Científicas (España) | - |
dc.date.priority | 2009-08-31 | - |
dc.identifier.citationapplication | PCT/IB2010/002340 | - |
dc.description.kind | A1 Solicitud de patentes con informe sobre el estado de la técnica | - |
item.openairetype | solicitud de patente | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IQAC) Patentes |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
WO2011024078A1.pdf | 3,03 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
306
checked on 23-abr-2024
Download(s)
100
checked on 23-abr-2024
Google ScholarTM
Check
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.